These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 32302946)

  • 61. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.
    Gangishetti U; Christina Howell J; Perrin RJ; Louneva N; Watts KD; Kollhoff A; Grossman M; Wolk DA; Shaw LM; Morris JC; Trojanowski JQ; Fagan AM; Arnold SE; Hu WT
    Alzheimers Res Ther; 2018 Sep; 10(1):98. PubMed ID: 30253800
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
    Mazzeo S; Santangelo R; Bernasconi MP; Cecchetti G; Fiorino A; Pinto P; Passerini G; Falautano M; Comi G; Magnani G
    J Alzheimers Dis; 2016 Oct; 54(4):1495-1508. PubMed ID: 27589522
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
    Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
    Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Early diagnosis of mild cognitive impairment and Alzheimer's with event-related potentials and event-related desynchronization in N-back working memory tasks.
    Fraga FJ; Mamani GQ; Johns E; Tavares G; Falk TH; Phillips NA
    Comput Methods Programs Biomed; 2018 Oct; 164():1-13. PubMed ID: 30195417
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
    Engelborghs S
    Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A promising method to distinguish vascular dementia from Alzheimer's disease with standardized low-resolution brain electromagnetic tomography and quantitative EEG.
    Wu L; Wu L; Chen Y; Zhou J
    Clin EEG Neurosci; 2014 Jul; 45(3):152-7. PubMed ID: 24214287
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia.
    Yu P; Dean RA; Hall SD; Qi Y; Sethuraman G; Willis BA; Siemers ER; Martenyi F; Tauscher JT; Schwarz AJ
    J Alzheimers Dis; 2012; 32(2):373-85. PubMed ID: 22796873
    [TBL] [Abstract][Full Text] [Related]  

  • 70. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer's disease.
    Gainotti G; Quaranta D; Vita MG; Marra C
    J Alzheimers Dis; 2014; 38(3):481-95. PubMed ID: 24002185
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multimodal EEG-MRI in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Colloby SJ; Cromarty RA; Peraza LR; Johnsen K; Jóhannesson G; Bonanni L; Onofrj M; Barber R; O'Brien JT; Taylor JP
    J Psychiatr Res; 2016 Jul; 78():48-55. PubMed ID: 27060340
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Correlate With Electroencephalography Parameters Assessed by Exact Low-Resolution Electromagnetic Tomography (eLORETA).
    Hata M; Tanaka T; Kazui H; Ishii R; Canuet L; Pascual-Marqui RD; Aoki Y; Ikeda S; Sato S; Suzuki Y; Kanemoto H; Yoshiyama K; Iwase M
    Clin EEG Neurosci; 2017 Sep; 48(5):338-347. PubMed ID: 27515698
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Novel Blood Biomarkers that Correlate with Cognitive Performance and Hippocampal Volumetry: Potential for Early Diagnosis of Alzheimer's Disease.
    Hudd F; Shiel A; Harris M; Bowdler P; McCann B; Tsivos D; Wearn A; Knight M; Kauppinen R; Coulthard E; White P; Conway ME
    J Alzheimers Dis; 2019; 67(3):931-947. PubMed ID: 30689581
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel.
    Babiloni C; Arakaki X; Azami H; Bennys K; Blinowska K; Bonanni L; Bujan A; Carrillo MC; Cichocki A; de Frutos-Lucas J; Del Percio C; Dubois B; Edelmayer R; Egan G; Epelbaum S; Escudero J; Evans A; Farina F; Fargo K; Fernández A; Ferri R; Frisoni G; Hampel H; Harrington MG; Jelic V; Jeong J; Jiang Y; Kaminski M; Kavcic V; Kilborn K; Kumar S; Lam A; Lim L; Lizio R; Lopez D; Lopez S; Lucey B; Maestú F; McGeown WJ; McKeith I; Moretti DV; Nobili F; Noce G; Olichney J; Onofrj M; Osorio R; Parra-Rodriguez M; Rajji T; Ritter P; Soricelli A; Stocchi F; Tarnanas I; Taylor JP; Teipel S; Tucci F; Valdes-Sosa M; Valdes-Sosa P; Weiergräber M; Yener G; Guntekin B
    Alzheimers Dement; 2021 Sep; 17(9):1528-1553. PubMed ID: 33860614
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Investigation of Simultaneous EEG and Eye Tracking Characteristics During Fixation Task in Mild Alzheimer's Disease.
    Moghadami M; Moghimi S; Moghimi A; Malekzadeh GR; Fadardi JS
    Clin EEG Neurosci; 2021 May; 52(3):211-220. PubMed ID: 32539459
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project.
    Wimo A; Kirsebom BE; Timón-Reina S; Vromen E; Selnes P; Bon J; Emersic A; Kramberger MG; Speh A; Visser PJ; Winblad B; Fladby T
    Int J Geriatr Psychiatry; 2024 Jul; 39(7):e6126. PubMed ID: 39030788
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [EEG changes in patients with Alzheimer's disease].
    Burd SG; Lebedeva AV; Rubleva YV; Pantina NV; Efimenko AP; Kovaleva II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4. Vyp. 2):72-76. PubMed ID: 38696154
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnosis and biomarkers of predementia in Alzheimer's disease.
    Forlenza OV; Diniz BS; Gattaz WF
    BMC Med; 2010 Dec; 8():89. PubMed ID: 21176189
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease.
    Wierenga CE; Bondi MW
    Neuropsychol Rev; 2007 Jun; 17(2):127-43. PubMed ID: 17476598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.